Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
ARDS: early-phase trial registry
10 of 15 indexed ARDS trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #1,140 of 28,707 conditions by registered trial count.
15 US clinical trials · 10 currently recruiting · #1,140 of 28,707 conditions by registered trial count
ARDS: 15 US clinical trials tracked, 10 recruiting.
ARDS is the subject of 15 registered US clinical trials on ClinicalTrials.gov, 10 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 6 in Phase 1-2 (earlier-stage). The most active sponsor is PPD Development, running 4 of these trials.
Enrollment posture brief
Registry condition ards
OPEN 10 | RECR 67% | LATE 1 | EARLY 6 | RANK #1140 | SPON 4
Volume-matched condition peers
Nearest open-share peer: Acute Hypoxemic Respiratory Failure (67% recruiting · 6 trials)
ARDS lists 10 open slots (67% of 15 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for ARDS on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
ARDS is recruiting above its size-band peers.
10 of 15 indexed trials (66.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates ARDS research.
PPD Development accounts for 4 of 15 trials (26.7%). 12 distinct sponsors appear on at least one study for this condition label.
-
Typical ARDS enrolment sits around 200 participants.
Median target enrolment is 200 among the 15 trials that report a genuine target (sentinel values excluded). 6 of those (40%) plan for fewer than 100 participants.
-
ARDS research is mostly interventional.
12 interventional and 3 observational studies make up this index (80% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
15 total, page 1 of 1
The APS Phenotyping Study
Vanderbilt University Medical Center
NCT06521502
Extracellular Vesicle Treatment for Acute Respiratory Distress Syndrome (ARDS) (EXTINGUISH ARDS)
Direct Biologics
NCT05354141
Respiratory Knowledge Portal Computer and Phone Application to Improve Quality of Mechanical Ventilation by Reducing the Number of Ventilator Associated Events, Injury Created by the Ventilator and Unsafe Setting of Alarms.
The University of Texas Medical Branch, Galveston
NCT06737432
Careful Ventilation in Acute Respiratory Distress Syndrome (COVID-19 and Non-COVID-19)
Unity Health Toronto
NCT03963622
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)
PPD Development
NCT06703073
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab
PPD Development
NCT06701656
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort A: Vilobelimab
PPD Development
NCT06701682
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort B: Paridiprubart
PPD Development
NCT06701669
Clinical Decision Support Tool in PARDS Pilot Study
Children's Hospital Los Angeles
NCT04068012
Ventilatory Parameters in Predicting Outcomes in ARDS Patients
CentraCare
NCT06400095
Retrospective Postoperative ARDS Study at Vanderbilt University
Vanderbilt University
NCT00656071
A Study of APL-9 in Adults With Mild to Moderate ARDS Due to COVID-19
Apellis Pharmaceuticals
NCT04402060
Novel Arm Restraint For Critically Ill Patients To Reduce Immobility, Sedation, Agitation and Cognitive Impairment
University of Vermont
NCT04067622
REgulatory T Cell infuSion fOr Lung Injury Due to COVID-19 PnEumonia
Cellenkos
NCT04468971
Electrical Impedance Tomography (EIT) Monitoring in Adults With ALI or ARDS
Christiana Care Health Services
NCT01272882
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 4 |
| Phase 3 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on ARDS records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on ARDS trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this ARDS page
15 registered trials, 10 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 10 ARDS trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- PPD Development sponsors the most ARDS trials on record, review their full trial history before evaluating a specific study. See PPD Development's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This ARDS condition card totals 15 registered trials; most-linked intervention Cohort C: bevacizumab; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.